196 related articles for article (PubMed ID: 15555001)
1. A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients.
Lawrance IC; Murray K; Hall A; Sung JJ; Leong R
Am J Gastroenterol; 2004 Nov; 99(11):2186-94. PubMed ID: 15555001
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of goblet cell and pancreatic exocine autoantibodies combined with ASCA and pANCA in Chinese and Caucasian patients with IBD.
Lawrance IC; Hall A; Leong R; Pearce C; Murray K
Inflamm Bowel Dis; 2005 Oct; 11(10):890-7. PubMed ID: 16189418
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease.
Nisihara RM; de Carvalho WB; Utiyama SR; Amarante H; Baptista ML
Dig Dis Sci; 2010 Aug; 55(8):2309-15. PubMed ID: 19826949
[TBL] [Abstract][Full Text] [Related]
4. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic role of anti-saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease].
Gao X; Hu PJ; He Y; Liao SY; Peng S; Chen MH
Zhonghua Nei Ke Za Zhi; 2005 Jun; 44(6):428-30. PubMed ID: 16008854
[TBL] [Abstract][Full Text] [Related]
6. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease.
Koutroubakis IE; Petinaki E; Mouzas IA; Vlachonikolis IG; Anagnostopoulou E; Castanas E; Maniatis AN; Kouroumalis EA
Am J Gastroenterol; 2001 Feb; 96(2):449-54. PubMed ID: 11232689
[TBL] [Abstract][Full Text] [Related]
7. The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease in mainland China.
Zhou F; Xia B; Wang F; Shrestha UK; Chen M; Wang H; Shi X; Chen Z; Li J
Clin Chim Acta; 2010 Oct; 411(19-20):1461-5. PubMed ID: 20570669
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody in Iranian patients with inflammatory bowel disease.
Bahari A; Aarabi M; Aarabi M; Hedayati M; Jarollahi A; Firouzi F; Aghazadeh R; Zali MR; Hashemi M
Acta Gastroenterol Belg; 2009; 72(3):301-5. PubMed ID: 19902862
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of serological markers in inflammatory bowel disease.
Mokrowiecka A; Daniel P; Słomka M; Majak P; Malecka-Panas E
Hepatogastroenterology; 2009; 56(89):162-6. PubMed ID: 19453050
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
Reese GE; Constantinides VA; Simillis C; Darzi AW; Orchard TR; Fazio VW; Tekkis PP
Am J Gastroenterol; 2006 Oct; 101(10):2410-22. PubMed ID: 16952282
[TBL] [Abstract][Full Text] [Related]
12. Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis.
Dendrinos KG; Becker JM; Stucchi AF; Saubermann LJ; LaMorte W; Farraye FA
J Gastrointest Surg; 2006; 10(7):1060-4. PubMed ID: 16843878
[TBL] [Abstract][Full Text] [Related]
13. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.
Quinton JF; Sendid B; Reumaux D; Duthilleul P; Cortot A; Grandbastien B; Charrier G; Targan SR; Colombel JF; Poulain D
Gut; 1998 Jun; 42(6):788-91. PubMed ID: 9691915
[TBL] [Abstract][Full Text] [Related]
14. pANCA and ASCA in Children with IBD-Unclassified, Crohn's Colitis, and Ulcerative Colitis-A Longitudinal Report from the IBD Porto Group of ESPGHAN.
Birimberg-Schwartz L; Wilson DC; Kolho KL; Karolewska-Bochenek K; Afzal NA; Spray C; Romano C; Lionetti P; Hauer AC; Martinez-Vinson C; Veres G; Escher JC; Turner D;
Inflamm Bowel Dis; 2016 Aug; 22(8):1908-14. PubMed ID: 27135480
[TBL] [Abstract][Full Text] [Related]
15. The value of serologic markers in indeterminate colitis: a prospective follow-up study.
Joossens S; Reinisch W; Vermeire S; Sendid B; Poulain D; Peeters M; Geboes K; Bossuyt X; Vandewalle P; Oberhuber G; Vogelsang H; Rutgeerts P; Colombel JF
Gastroenterology; 2002 May; 122(5):1242-7. PubMed ID: 11984510
[TBL] [Abstract][Full Text] [Related]
16. ASCA and ANCA among Bedouin Arabs with inflammatory bowel disease, the frequency and phenotype correlation.
Abu-Freha N; Badarna W; Sigal-Batikoff I; Abu Tailakh M; Etzion O; Elkrinawi J; Segal A; Mushkalo A; Fich A
BMC Gastroenterol; 2018 Oct; 18(1):153. PubMed ID: 30342474
[TBL] [Abstract][Full Text] [Related]
17. Optimising the diagnostic value of anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn's disease.
Klebl FH; Bataille F; Hofstädter F; Herfarth H; Schölmerich J; Rogler G
Int J Colorectal Dis; 2004 Jul; 19(4):319-24. PubMed ID: 14745572
[TBL] [Abstract][Full Text] [Related]
18. pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease.
Mokrowiecka A; Gasiorowska A; Malecka-Panas E
Hepatogastroenterology; 2007; 54(77):1443-8. PubMed ID: 17708273
[TBL] [Abstract][Full Text] [Related]
19. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
[TBL] [Abstract][Full Text] [Related]
20. [Interest of serologic markers in inflammatory bowel disease. About 105 cases].
Fekih M; Ben Hlima S; Zitouni M; Matri S; Boubaker J; Makni S; Azza F
Tunis Med; 2007 Oct; 85(10):821-8. PubMed ID: 18236802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
